Real World Outcomes of Immunotherapy (IO) for Pleural MESOthelioma in Australia - RIOMeso

被引:0
|
作者
McNamee, N. [1 ,2 ,3 ]
Harvey, C. [2 ]
Gray, L. [2 ]
Khoo, T. [4 ]
Lingam, L. [5 ]
Zhang, B. [6 ]
Clay, T. [7 ,8 ]
Arulananda, S. [9 ,10 ]
Itchins, M. [11 ,12 ]
Pavlakis, N. [11 ,12 ,13 ]
Kao, S. [12 ]
Bowyer, S. [13 ]
Chin, V. [14 ]
Warburton, L.
da Silva, I. [15 ]
John, T. [16 ]
Solomon, B. [16 ]
Alexander, M. [16 ,17 ]
Nagrial, A. [2 ,15 ]
机构
[1] Kinghorn Canc Ctr, Sydney, NSW, Australia
[2] Westmead Hosp, Sydney, NSW, Australia
[3] Garvan Inst Med Res, Sydney, NSW, Australia
[4] Sir Charles Gairdner Hosp, Perth, WA, Australia
[5] Fiona Stanley Hosp, Perth, WA, Australia
[6] Chris OBrien Lifehouse, Sydney, NSW, Australia
[7] St John God Subiaco, Perth, WA, Australia
[8] Edith Cowan Univ, Perth, WA, Australia
[9] Monash Hlth, Melbourne, Vic, Australia
[10] Monash Univ, Melbourne, Vic, Australia
[11] Royal North Shore Hosp, Sydney, NSW, Australia
[12] Univ Sydney, Sydney, NSW, Australia
[13] Univ Western Australia, Perth, WA, Australia
[14] Univ New South Wales, Sydney, NSW, Australia
[15] Blacktown Hosp, Sydney, NSW, Australia
[16] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[17] Univ Melbourne, Melbourne, Vic, Australia
关键词
mesothelioma; immunotherapy; real-world;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MA17.05
引用
收藏
页码:S163 / S163
页数:1
相关论文
共 50 条
  • [1] Brief Report: Real-World Toxicity and Survival of Combination Immunotherapy in Pleural Mesothelioma-RIOMeso
    McNamee, Nicholas
    Harvey, Catriona
    Gray, Lauren
    Khoo, Trisha
    Lingam, Lavanya
    Zhang, Betty
    Nindra, Udit
    Yip, Po Yee
    Pal, Abhijit
    Clay, Timothy
    Arulananda, Surein
    Itchins, Malinda
    Pavlakis, Nick
    Kao, Steven
    Bowyer, Samantha
    Chin, Venessa
    Warburton, Lydia
    Silva, Ines Pires da
    John, Thomas
    Solomon, Benjamin
    Alexander, Marliese
    Nagrial, Adnan
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (04) : 636 - 642
  • [2] Real-world outcomes and molecular correlates of incorporating immunotherapy (IO) and bevacizumab (Bev) in treating patients with peritoneal mesothelioma (PeM): A comparative analysis with pleural mesothelioma (PM)
    Huey, Ryan W.
    Gandhi, Nishant
    Helmink, Beth A.
    Overman, Michael J.
    Malpica, Anais
    Estrella, Jeannelyn
    Taggart, Melissa
    Allam, Joelle
    Scally, Christopher
    Mansfield, Paul F.
    Matamoros, Aurelio
    Elliott, Andrew
    VanderWalde, Ari
    Ma, Patrick C.
    Halmos, Balazs
    Liu, Stephen V.
    Fournier, Keith F.
    Raghav, Kanwal Pratap Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Real-World Immunotherapy Use in Pleural Mesothelioma: Insights & Immunological Landscape
    Xu, X.
    Shou, J.
    Wang, D.
    Ye, L.
    Fang, Y.
    Fang, M.
    Mao, W.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S277 - S277
  • [4] Immunotherapy Is a Good Standard Option for Patients With Malignant Pleural Mesothelioma, Despite the Real-World Results From Australia
    Smesseim, Illaa
    Baas, Paul
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (04) : 547 - 550
  • [5] Real-world outcomes for patients with pleural mesothelioma: A multisite retrospective cohort study
    Chow, Kar Ven Cavan
    Turner, Cassie
    Hughes, Brett
    Houston, Kathleen
    Lwin, Zarnie
    Chan, Bryan
    RESPIROLOGY, 2023, 28 : 25 - 25
  • [6] Real-world outcomes for patients with pleural mesothelioma: A multisite retrospective cohort study
    Chow, Kar Ven Cavan
    Turner, Cassie
    Hughes, Brett
    Lwin, Zarnie
    Chan, Bryan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 (06) : 723 - 730
  • [7] Real-world outcomes for patients with pleural mesothelioma: A multisite retrospective cohort study
    Chow, Kar Ven Cavan K. V. C. C.
    Turner, CassieC. T.
    Hughes, BrettB. H.
    Houston, Kathleen K. H.
    Lwin, Zarnie Z. L.
    Chan, Bryan B. C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 159 - 159
  • [8] Based on the Real-World Results From Australia, Immunotherapy Is Not a Good Option for Patients With Mesothelioma
    Gray, Steven G.
    Meirson, Tomer
    Mutti, Luciano
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (04) : 541 - 546
  • [9] Pleural Mesothelioma in the Era of Immunotherapy
    Chevallier, Mathieu
    Kim, Floryane
    Friedlaender, Alex
    Addeo, Alfredo
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2023, 17
  • [10] Immunotherapy in Malignant Pleural Mesothelioma
    de Gooijer, Cornedine J.
    Borm, Frank J.
    Scherpereel, Arnaud
    Baas, Paul
    FRONTIERS IN ONCOLOGY, 2020, 10